These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26682548)

  • 21. Patient preferences for treatment in type 2 diabetes: the Italian discrete-choice experiment analysis.
    Marchesini G; Pasqualetti P; Anichini R; Caputo S; Memoli G; Ponzani P; Resi V; Rizzo M; Serviddio G; Zanette G
    Acta Diabetol; 2019 Mar; 56(3):289-299. PubMed ID: 30306406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
    Lloyd A; Nafees B; Barnett AH; Heller S; Ploug UJ; Lammert M; Bøgelund M
    Clin Ther; 2011 Sep; 33(9):1258-67. PubMed ID: 21862132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Preferences for Medications in Managing Type 2 Diabetes Mellitus: A Discrete Choice Experiment.
    Ozdemir S; Baid D; Verghese NR; Lam AY; Lee PC; Lim AY; Zhu L; Ganguly S; Finkelstein EA; Goh SY
    Value Health; 2020 Jul; 23(7):842-850. PubMed ID: 32762985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient preferences for diabetes treatment attributes and drug classes.
    Flood EM; Bell KF; de la Cruz MC; Ginchereau-Sowell FM
    Curr Med Res Opin; 2017 Feb; 33(2):261-268. PubMed ID: 27779433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.
    Hauber AB; Mohamed AF; Johnson FR; Falvey H
    Diabet Med; 2009 Apr; 26(4):416-24. PubMed ID: 19388973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A discrete-choice experiment to elicit preferences of patients with epilepsy for self-management programs.
    Atkinson-Clark E; Charokopou M; Van Osselaer N; Hiligsmann M
    Epilepsy Behav; 2018 Feb; 79():58-67. PubMed ID: 29248866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding drug preferences, different perspectives.
    Mol PG; Arnardottir AH; Straus SM; de Graeff PA; Haaijer-Ruskamp FM; Quik EH; Krabbe PF; Denig P
    Br J Clin Pharmacol; 2015 Jun; 79(6):978-87. PubMed ID: 25469876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
    Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
    Patient; 2012; 5(1):33-44. PubMed ID: 22077619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
    Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
    Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes.
    Janssen EM; Segal JB; Bridges JF
    Patient; 2016 Oct; 9(5):465-79. PubMed ID: 27120338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia.
    Balasubramaniam S; Lim SL; Goh LH; Subramaniam S; Tangiisuran B
    Diabetes Metab Syndr; 2019; 13(4):2585-2591. PubMed ID: 31405680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.
    Liu S; Liu J; Si L; Ke X; Liu L; Ren Y; Bao S; Li F; Yu Y; Pan Q; Wei Y; Chen Y
    BMJ Glob Health; 2023 Apr; 8(4):. PubMed ID: 37041021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
    de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
    Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient Preferences for Diabetes Treatment Among People With Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
    Huang Y; Huang Q; Xu A; Lu M; Xi X
    Front Public Health; 2021; 9():782964. PubMed ID: 35178370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First and Foremost Battle the Virus: Eliciting Patient Preferences in Antiviral Therapy for Hepatitis C Using a Discrete Choice Experiment.
    Mühlbacher A; Bethge S
    Value Health; 2016; 19(6):776-787. PubMed ID: 27712705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.